Shifting Frontiers: Navigating the Evolution of Cell and Gene Therapies from Oncology to Autoimmune Studies

Desmond Cabrera is a seasoned global operations leader with extensive experience in biotechnology and pharmaceuticals. He specializes in cell and gene therapy and has led clinical trials across multiple therapeutic areas. As VP, Head of Global Operations for a mid-sized global CRO, Desmond oversees global project management teams, financial planning, and milestone delivery. His expertise in multinational team leadership, process optimization, and strategic partnerships consistently drives operational excellence and customer satisfaction. Desmond’s track record in advancing clinical development and executing high-stakes negotiations has been instrumental in achieving corporate goals and ensuring long-term success.

Dr. Danielly Vicente is a physician-scientist with over 14 years of experience in hematology and oncology. As Associate Medical Director at Allucent, Danielly oversees medical monitoring for clinical studies, provides protocol guidance, and supports safety and data review. Her career spans both clinical and industry settings. She has managed and treated patients with a wide range of hematological and oncological diseases in private practice and has held key roles in the pharmaceutical industry. Her expertise encompasses the diagnosis and treatment of complex blood disorders, hematopoietic stem cell transplantation, and the development of clinical protocols for oncology and hematology.

Stephanie, a Project Director specializing in Cell and Gene Therapy at Allucent, has over 15 years of clinical research experience. She oversees clinical trials, ensuring client satisfaction, timelines, and budgets while managing technical and operational aspects. Beginning in oncology at the site level, she advanced to clinical trial lead and has worked in project management since 2012. With expertise in 75+ studies across Phases I-III, oncology, immuno-oncology, and advanced therapies, she has extensive PK/PD and tumor tissue collection experience. Previously, she was a Program Manager at Tempus Labs. Stephanie holds a Microbiology degree from Michigan State University.